Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

1(33.3%)

Phase 4

1(33.3%)

N/A

1(33.3%)

3Total

Phase 3(1)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07504575Recruiting

Effect of PRP in Donor Semen During Cryoprervation

Role: lead

NCT07376460Not Yet Recruiting

Proteomic and Biological Characterisation of Plasma for the Study of Changes Following Ovarian Reactivation Treatment

Role: lead

NCT03741699Phase 3Completed

Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH)

Role: lead

NCT04784260Completed

Microbiome Influence on Seminal Quality

Role: lead

NCT01955356Not ApplicableCompleted

Embryo Implantation After Induced Endometrial Injury

Role: collaborator

NCT02535377Completed

Human Sperm Markers of Cryodamage Resistance

Role: lead

NCT02527954Terminated

Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions

Role: lead

NCT02213627Phase 4Unknown

Use of Corifolitropin Alfa in Oocyte Donors

Role: collaborator

All 8 trials loaded